Ultragenyx Pharmaceutical
RARE
RARE
176 hedge funds and large institutions have $4.05B invested in Ultragenyx Pharmaceutical in 2019 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 89 increasing their positions, 31 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
7% more funds holding
Funds holding: 164 → 176 (+12)
2.09% more ownership
Funds ownership: 100.11% → 102.21% (+2.1%)
Holders
176
Holding in Top 10
2
Calls
$22.7M
Puts
$11.2M
Top Buyers
| 1 | +$67.9M | |
| 2 | +$66.8M | |
| 3 | +$53.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.8M |
| 5 |
Alkeon Capital Management
New York
|
+$45.2M |
Top Sellers
| 1 | -$29.8M | |
| 2 | -$22.6M | |
| 3 | -$12.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$9.01M |
| 5 |
Morgan Stanley
New York
|
-$8.64M |